U.S. News and World Report, February 29, 2016. With FDA’s plan to warn consumers about the birth contraceptive implant Essure, Diana Zuckerman at The National Center for Health Research shares: “We strongly support a black box warning, but it needs to be a very strong one.”
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Birth Control Device Slapped with Warnings About Dangerous Side Effects
Buzzfeed, February 29. 2016. After months of debate, the FDA is acknowledging the serious risks that come with the Essure sterilization device. But many women are angry it hasn’t been pulled from the market.
Read More »FDA Recommends Black Box on Essure, Says It Requires Further Study
Modern Health, February 29, 2016. National Center for Health Research’s president Dr. Diana Zuckerman advises that the warning label on Essure implant contraceptive and the studies to be performed on Essure by Bayer, the company that makes the product, must both be under close watch.
Read More »2016 Foremother and Health Policy Heroes Awards Luncheon Invitation
February 26, 2016. Find out the details for NCHR’s 2016 Awards Luncheon honoring women for a lifetime of breaking down barriers.
Read More »Critics See Accountability Risk If FDA Rule Changes Take Hold
Star Tribune, February 14, 2016. A move to relax labeling requirements for drugs and medical devices has some patient advocates concerned that people will have a tougher time holding manufacturers accountable for injuries caused by their products.
Read More »